BridgeBio Pharma (BBIO) Cash from Operations Growth (1y) (2019 - 2026)
BridgeBio Pharma (BBIO) Cash from Operations Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | 7.14% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn | 356.73% |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | 74.39% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | 3.23% |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | BridgeBio Pharma | 16.71 Bn | 15.77 Bn | 184.58 Mn | 0.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.98% |
| Dec 31, 2025 | 71.11% |
| Sep 30, 2025 | 39.32% |
| Jun 30, 2025 | -208.00% |
| Mar 31, 2025 | 9.25% |
| Dec 31, 2024 | -56.49% |
| Sep 30, 2024 | -24.33% |
| Jun 30, 2024 | 165.90% |
| Mar 31, 2024 | -52.12% |
| Dec 31, 2023 | -33.86% |
| Sep 30, 2023 | -7.45% |
| Jun 30, 2023 | -272.22% |
| Mar 31, 2023 | 10.16% |
| Dec 31, 2022 | 30.36% |
| Sep 30, 2022 | -11.19% |
| Jun 30, 2022 | 66.80% |
| Mar 31, 2022 | -6.55% |
| Dec 31, 2021 | -39.10% |
| Sep 30, 2021 | 7.69% |
| Jun 30, 2021 | -4.40% |